Granza Bio
Building programmable therapeutics for the immune system
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity. Granza Bio is a Y Combinator company (Winter 2024). YC-listed status: Active.
- Website
- granzabio.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Links
- Y Combinator profileycombinator